Johnson & Johnson Loses Key Tuberculosis Drug Patent In India

The Indian Patent Office on Thursday rejected US pharmaceutical giant Johnson and Johnson's application to extend its patent on a key tuberculosis treatment, allowing local companies to make cheaper...